Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Post by Roundingerroron Jan 01, 2016 4:33pm
109 Views
Post# 24424041

Nope!

Nope!I can't think of a single reason why I would vote in favour of this.

My entire investment is in my TFSA, so I can't write off the loss and the offer is a fraction of my average purchase price.   I guess it's possible that some other company down the road will offer less, but we are so close to rock bottom, I'd be willing to throw those dice.  

I would assume, however there are much larger investors out there who could use a tax loss or have been smart enough to average down over these many years, that they will wind up with a much smaller -- if any - loss,  For this reason, I would expect this thing will sail through.

It seems such a shame to see this thing sold at a fire sale price when there appears not to have been any fire.



<< Previous
Bullboard Posts
Next >>